dsRNA Sensing Induces Loss of Cell Identity.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
01 2019
Historique:
received: 27 04 2018
revised: 20 06 2018
accepted: 13 07 2018
pubmed: 19 8 2018
medline: 2 11 2019
entrez: 19 8 2018
Statut: ppublish

Résumé

How cell and tissue identity persist despite constant cell turnover is an important biologic question with cell therapy implications. Although many mechanisms exist, we investigated the controls for site-specific gene expression in skin, given its diverse structures and functions. For example, the transcriptome of in vivo palmoplantar (i.e., volar) epidermis is globally unique, including Keratin 9 (KRT9). Although volar fibroblasts have the capacity to induce KRT9 in nonvolar keratinocytes, we show here that volar keratinocytes continue to express KRT9 in in vitro solo cultures. Despite this, KRT9 expression is lost with volar keratinocyte passaging, despite stable hypomethylation of its promoter. Coincident with KRT9 loss is a gain of the primitive keratin 7 and a signature of dsRNA sensing, including the double-stranded RNA (dsRNA) receptor DExD/H-Box Helicase 58 (DDX58/RIG-I). Exogenous dsRNA inhibits KRT9 expression in early passage volar keratinocytes or in vivo footpads of wild-type mice. Loss of DDX58 in passaged volar keratinocytes rescues KRT9 and inhibits KRT7 expression. Additionally, DDX58-null mice are resistant to the ability of dsRNA to inhibit KRT9 expression. These results show that the sensing of dsRNA is critical for loss of cell-specific gene expression; our results have important implications for how dsRNA sensing is important outside of immune pathways.

Identifiants

pubmed: 30120933
pii: S0022-202X(18)32468-0
doi: 10.1016/j.jid.2018.07.021
pmc: PMC6379068
mid: NIHMS1006925
pii:
doi:

Substances chimiques

KRT9 protein, human 0
Keratin-9 0
RNA, Double-Stranded 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-99

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR064297
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR068280
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Oncotarget. 2016 May 3;7(18):26496-515
pubmed: 27034163
Am J Pathol. 2016 May;186(5):1140-50
pubmed: 27105735
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12877-82
pubmed: 12297622
Protein Cell. 2018 Mar;9(3):246-253
pubmed: 28593618
J Invest Dermatol. 2014 Mar;134(3):754-763
pubmed: 23962810
Development. 2005 Apr;132(7):1499-509
pubmed: 15728671
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Sci Transl Med. 2014 Nov 26;6(264):264ra163
pubmed: 25429056
J Invest Dermatol. 2017 Jul;137(7):1562-1568
pubmed: 28392344
Nat Med. 2012 Aug;18(8):1286-90
pubmed: 22772463
J Invest Dermatol. 1999 Apr;112(4):483-8
pubmed: 10201533
J Embryol Exp Morphol. 1973 Dec;30(3):587-603
pubmed: 4772387
Cell. 2018 Jan 25;172(3):423-438.e25
pubmed: 29249360
Eur J Dermatol. 2009 Mar-Apr;19(2):114-8
pubmed: 19106041
Cell Stem Cell. 2015 Aug 6;17(2):139-51
pubmed: 26253200
J Exp Med. 1967 Mar 1;125(3):429-46
pubmed: 5334545
Nature. 2017 Nov 16;551(7680):327-332
pubmed: 29144448
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19679-88
pubmed: 24145441
J Invest Dermatol. 2016 Aug;136(8):1647-1655
pubmed: 26994968
N Engl J Med. 1963 Mar 7;268:539-45 concl
pubmed: 13968274
Nat Genet. 1994 Feb;6(2):174-9
pubmed: 7512862
Exp Cell Res. 1989 Sep;184(1):193-206
pubmed: 2477265
J Invest Dermatol. 2016 Aug;136(8):1538-1540
pubmed: 27450498
J Invest Dermatol. 2002 Feb;118(2):216-25
pubmed: 11841536
Sci Transl Med. 2014 Nov 26;6(264):264ra164
pubmed: 25429057
PLoS One. 2013 May 31;8(5):e64404
pubmed: 23741325
J Cell Biol. 1986 Aug;103(2):657-67
pubmed: 2426283
Nature. 1984 Oct 11-17;311(5986):560-2
pubmed: 6482967
Nat Med. 2006 Dec;12(12):1397-402
pubmed: 17115047

Auteurs

Rongying Zhou (R)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.

Gaofeng Wang (G)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.

Dongwon Kim (D)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Sooah Kim (S)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Nasif Islam (N)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Ruosi Chen (R)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.

Zixiao Wang (Z)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Ang Li (A)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Edward F McCarthy (EF)

Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Li Li (L)

Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.

Zhiqi Hu (Z)

Department of Plastic and Aesthetic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China.

Luis A Garza (LA)

Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Electronic address: LAG@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH